Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice

Human Molecular Genetics

Volumn 22, Issue 5, 2013, Pages 867-878

  Enwere, Emeka K ^a,b   Boudreault, Louise ^a   Holbrook, Janelle ^b   Timusk, Kristen ^a,b   Earl, Nathalie ^b   Lacasse, Eric ^b   Renaud, Jean Marc ^a   Korneluk, Robert G ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CELLULAR INHIBITOR OF APOPTOSIS 1; DYSTROPHIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN P52; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL INFILTRATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; ENDURANCE; FEMALE; GENE LOSS; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; MUSCLE INJURY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLEUS MUSCLE; TREADMILL EXERCISE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CREATINE KINASE; DIAPHRAGM; DYSTROPHIN; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTERLEUKIN-6; MICE; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NF-KAPPA B; PHYSICAL ENDURANCE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873469202     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds493     Document Type: Article

References (66)

1. Hoffman, E.P., Brown, R.H. Jr and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
2. Ryder-Cook, A.S., Sicinski, P., Thomas, K., Davies, K.E., Worton, R.G., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1988) Localization of the mdx mutation within the mouse dystrophin gene. EMBO J., 7, 3017-3021.
3. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
4. Messina, S., Bitto, A., Aguennouz, M., Minutoli, L., Monici, M.C., Altavilla, D., Squadrito, F. and Vita, G. (2006) Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. Exp. Neurol., 198, 234-241.
5. Acharyya, S., Villalta, S.A., Bakkar, N., Bupha-Intr, T., Janssen, P.M., Carathers, M., Li, Z.W., Beg, A.A., Ghosh, S., Sahenk, Z. et al. (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest., 117, 889-901.
6. Acharyya, S., Sharma, S.M., Cheng, A.S., Ladner, K.J., He, W., Kline, W., Wang, H., Ostrowski, M.C., Huang, T.H. and Guttridge, D.C. (2010) TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in Duchenne muscular dystrophy. PloS One, 5, e12479.
7. Mahoney, D.J., Cheung, H.H., Mrad, R.L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T.W., Lacasse, E.C., Waring, J. et al. (2008) Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl Acad. Sci. USA, 105, 11778-11783.
8. Zarnegar, B.J., Wang, Y., Mahoney, D.J., Dempsey, P.W., Cheung, H.H., He, J., Shiba, T., Yang, X., Yeh, W.C., Mak, T.W. et al. (2008) Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol., 9, 1371-1378.
9. Vince, J.E., Chau, D., Callus, B., Wong, W.W., Hawkins, C.J., Schneider, P., McKinlay, M., Benetatos, C.A., Condon, S.M., Chunduru, S.K. et al. (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J. Cell Biol., 182, 171-184.
10. Varfolomeev, E., Goncharov, T., Maecker, H., Zobel, K., Komuves, L.G., Deshayes, K. and Vucic, D. (2012) Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci. Signal., 5, ra22.
11. Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.H., Keats, J.J., Wang, H., Vignali, D.A., Bergsagel, P.L. and Karin, M. (2008) Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol., 9, 1364-1370.
12. Bonizzi, G., Bebien, M., Otero, D.C., Johnson-Vroom, K.E., Cao, Y., Vu, D., Jegga, A.G., Aronow, B.J., Ghosh, G., Rickert, R.C. et al. (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J., 23, 4202-4210.
13. Smale, S.T. (2012) Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors. Immunol. Rev., 246, 193-204.
14. Arany, Z., Lebrasseur, N., Morris, C., Smith, E., Yang, W., Ma, Y., Chin, S. and Spiegelman, B.M. (2007) The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab., 5, 35-46.
15. Bakkar, N., Wang, J., Ladner, K.J., Wang, H., Dahlman, J.M., Carathers, M., Acharyya, S., Rudnicki, M.A., Hollenbach, A.D. and Guttridge, D.C. (2008) IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol., 180, 787-802.
16. Bakkar, N., Ladner, K., Canan, B.D., Liyanarachchi, S., Bal, N.C., Pant, M., Periasamy, M., Li, Q., Janssen, P.M. and Guttridge, D.C. (2012) IKKalpha and alternative NF-kappaB regulate PGC-1beta to promote oxidative muscle metabolism. J. Cell Biol., 196, 497-511.
17. Enwere, E.K., Holbrook, J., Lejmi-Mrad, R., Vineham, J., Timusk, K., Sivaraj, B., Isaac, M., Uehling, D., Al-awar, R., LaCasse, E. et al. (2012) TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-kappaB signaling pathway. Sci. Signal., 5, ra75.
18. Saitoh, T., Nakayama, M., Nakano, H., Yagita, H., Yamamoto, N. and Yamaoka, S. (2003) TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J. Biol. Chem., 278, 36005-36012.
19. Conze, D.B., Albert, L., Ferrick, D.A., Goeddel, D.V., Yeh, W.C., Mak, T. and Ashwell, J.D. (2005) Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol., 25, 3348-3356.
20. Cheng, L., Gu, X., Sanderson, J.E., Wang, X., Lee, K., Yao, X., Liu, H., Cheung, W.L. and Li, M. (2006) A new function of a previously isolated compound that stimulates activation and differentiation of myogenic precursor cells leading to efficient myofiber regeneration and muscle repair. Int. J. Biochem. Cell Biol., 38, 1123-1133.
21. Stupka, N., Plant, D.R., Schertzer, J.D., Emerson, T.M., Bassel-Duby, R., Olson, E.N. and Lynch, G.S. (2006) Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice. J. Physiol., 575, 645-656.
22. Villalta, S.A., Nguyen, H.X., Deng, B., Gotoh, T. and Tidball, J.G. (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet., 18, 482-496.
23. Chihara, T., Hashimoto, M., Osman, A., Hiyoshi-Yoshidomi, Y., Suzu, I., Chutiwitoonchai, N., Hiyoshi, M., Okada, S. and Suzu, S. (2012) HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J. Immunol., 188, 3620-3627.
24. Sacco, P., Jones, D.A., Dick, J.R. and Vrbova, G. (1992) Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin. Sci. (Lond.), 82, 227-236.
25. Lynch, G.S. (2004) Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin. Exp. Pharmacol. Physiol., 31, 557-561.
26. Chan, S., Head, S.I. and Morley, J.W. (2007) Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am. J. Physiol. Cell Physiol., 293, C985-C992.
27. Wang, X., Weisleder, N., Collet, C., Zhou, J., Chu, Y., Hirata, Y., Zhao, X., Pan, Z., Brotto, M., Cheng, H. et al. (2005) Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. Nat. Cell Biol., 7, 525-530.
28. Constantin, B., Sebille, S. and Cognard, C. (2006) New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. J. Muscle Res. Cell Motil., 27, 375-386.
29. Turner, P.R., Westwood, T., Regen, C.M. and Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 335, 735-738.
30. Coulton, G.R., Curtin, N.A., Morgan, J.E. and Partridge, T.A. (1988) The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol. Appl. Neurobiol., 14, 299-314.
31. Consolino, C.M. and Brooks, S.V. (2004) Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice. J. Appl. Physiol., 96, 633-638.
32. Gumerson, J.D., Kabaeva, Z.T., Davis, C.S., Faulkner, J.A. and Michele, D.E. (2010) Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Am. J. Physiol. Cell Physiol., 299, C1430-C1440.
33. Spassov, A., Gredes, T., Gedrange, T., Lucke, S., Morgenstern, S., Pavlovic, D. and Kunert-Keil, C. (2011) Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice. Eur. J. Orthod., 33, 613-619.
34. Joanne, P., Hourde, C., Ochala, J., Cauderan, Y., Medja, F., Vignaud, A., Mouisel, E., Hadj-Said, W., Arandel, L., Garcia, L. et al. (2012) Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle. PloS One, 7, e35346.
35. Quinlan, J.G., Johnson, S.R. and Samaha, F.J. (1990) Dantrolene normalizes serum creatine kinase in MDX mice. Muscle Nerve, 13, 268-269.
36. Rooney, J.E., Gurpur, P.B. and Burkin, D.J. (2009) Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA, 106, 7991-7996.
37. Spurney, C.F., Gordish-Dressman, H., Guerron, A.D., Sali, A., Pandey, G.S., Rawat, R., Van Der Meulen, J.H., Cha, H.J., Pistilli, E.E., Partridge, T.A. et al. (2009) Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve, 39, 591-602.
38. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
39. Matecki, S., Guibinga, G.H. and Petrof, B.J. (2004) Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury. Am. J. Physiol. Regul. Integr. Comp. Physiol., 287, R961-R968.
40. Hnia, K., Tuffery-Giraud, S., Vermaelen, M., Hugon, G., Chazalette, D., Masmoudi, A., Rivier, F. and Mornet, D. (2006) Pathological pattern of Mdx mice diaphragm correlates with gradual expression of the short utrophin isoform Up71. Biochim. Biophys. Acta, 1762, 362-372.
41. Rando, T.A., Disatnik, M.H., Yu, Y. and Franco, A. (1998) Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul. Disord., 8, 14-21.
42. Sandri, M., Massimino, M.L., Cantini, M., Giurisato, E., Sandri, C., Arslan, P. and Carraro, U. (1998) Dystrophin deficient myotubes undergo apoptosis in mouse primary muscle cell culture after DNA damage. Neurosci. Lett., 252, 123-126.
43. Webster, C., Silberstein, L., Hays, A.P. and Blau, H.M. (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell, 52, 503-513.
44. Selsby, J.T., Morine, K.J., Pendrak, K., Barton, E.R. and Sweeney, H.L. (2012) Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PloS One, 7, e30063.
45. Gehrig, S.M., Koopman, R., Naim, T., Tjoakarfa, C. and Lynch, G.S. (2010) Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am. J. Pathol., 176, 29-33.
46. Ljubicic, V., Miura, P., Burt, M., Boudreault, L., Khogali, S., Lunde, J.A., Renaud, J.M. and Jasmin, B.J. (2011) Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum. Mol. Genet., 20, 3478-3493.
47. Cheung, H.H., Beug, S.T., St Jean, M., Brewster, A., Kelly, N.L., Wang, S. and Korneluk, R.G. (2010) Smac mimetic compounds potentiate interleukin-1beta-mediated cell death. J. Biol. Chem., 285, 40612-40623.
48. Reay, D.P., Yang, M., Watchko, J.F., Daood, M., O'Day, T.L., Rehman, K.K., Guttridge, D.C., Robbins, P.D. and Clemens, P.R. (2011) Systemic delivery of NEMO binding domain/IKKgamma inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology. Neurobiol. Dis., 43, 598-608.
49. Nakamura, A., Yoshida, K., Takeda, S., Dohi, N. and Ikeda, S. (2002) Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett., 520, 18-24.
50. Hnia, K., Hugon, G., Rivier, F., Masmoudi, A., Mercier, J. and Mornet, D. (2007) Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. Am. J. Pathol., 170, 633-643.
51. Shi, H., Boadu, E., Mercan, F., Le, A.M., Flach, R.J., Zhang, L., Tyner, K.J., Olwin, B.B. and Bennett, A.M. (2010) MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. FASEB J., 24, 2985-2997.
52. Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S. et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature, 479, 117-121.
53. Kenneth, N.S., Younger, J.M., Hughes, E.D., Marcotte, D., Barker, P.A., Saunders, T.L. and Duckett, C.S. (2012) An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. Biochem. J., 443, 355-359.
54. Akhter, A., Caution, K., Abu Khweek, A., Tazi, M., Abdulrahman, B.A., Abdelaziz, D.H., Voss, O.H., Doseff, A.I., Hassan, H., Azad, A.K. et al. (2012) Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity, 37, 35-47.
55. Rathinam, V.A., Vanaja, S.K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L.M., Leong, J.M. and Fitzgerald, K.A. (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell, 150, 606-619.
56. Mueller, N.J., Wilkinson, R.A. and Fishman, J.A. (2002) Listeria monocytogenes infection in caspase-11-deficient mice. Infect. Immun., 70, 2657-2664.
57. Broz, P., Ruby, T., Belhocine, K., Bouley, D.M., Kayagaki, N., Dixit, V.M. and Monack, D.M. (2012) Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature, 490, 288-291.
58. Bertrand, M.J., Doiron, K., Labbe, K., Korneluk, R.G., Barker, P.A. and Saleh, M. (2009) Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity, 30, 789-801.
59. Toussaint, M., Chatwin, M. and Soudon, P. (2007) Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chronic Respir. Dis., 4, 167-177.
60. Dupont-Versteegden, E.E. and McCarter, R.J. (1992) Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve, 15, 1105-1110.
61. Louboutin, J.P., Fichter-Gagnepain, V., Thaon, E. and Fardeau, M. (1993) Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul. Disord., 3, 463-469.
62. Bogdanovich, S., Krag, T.O., Barton, E.R., Morris, L.D., Whittemore, L.A., Ahima, R.S. and Khurana, T.S. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature, 420, 418-421.
63. Minetti, G.C., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Di Padova, M. et al. (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med., 12, 1147-1150.
64. Weisberg, E., Ray, A., Barrett, R., Nelson, E., Christie, A.L., Porter, D., Straub, C., Zawel, L., Daley, J.F., Lazo-Kallanian, S. et al. (2010) Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia, 24, 2100-2109.
65. Cifelli, C., Bourassa, F., Gariepy, L., Banas, K., Benkhalti, M. and Renaud, J.M. (2007) KATP channel deficiency in mouse flexor digitorum brevis causes fibre damage and impairs Ca2+ release and force development during fatigue in vitro. J. Physiol., 582, 843-857.
66. Steel, R.G. and Torrie, J.H. (1980) Principles and Procedures of Statistics: A Biometrical Approach. McGraw-Hill, New York, NY.